A rare autoimmune disorder has left a 17-year-old California teen battling a condition that mimics diabetes while simultaneously attacking two critical hormone systems, medical experts confirmed this week. The case of Emma Rodriguez—diagnosed with Autoimmune Polyglandular Syndrome Type 2 (APS-2)—has drawn attention to the complexities of diagnosing and managing disorders that disrupt multiple endocrine functions.
When the Body Turns Against Itself
APS-2, also known as Schmidt syndrome, is a rare autoimmune condition where the immune system mistakenly targets healthy tissues in the adrenal glands, thyroid, and often the pancreas. In Emma’s case, the disorder triggered Addison’s disease—a life-threatening deficiency in cortisol and aldosterone production—and type 1 diabetes, where the immune system destroys insulin-producing cells in the pancreas.
“The overlap of symptoms made this particularly challenging,” said Dr. Lisa Chen, an endocrinologist at Stanford Children’s Health, who is overseeing Emma’s treatment. “Fatigue, weight loss, and frequent urination are classic signs of diabetes, but when paired with low blood pressure and darkening skin, it pointed to something far more complex.”
According to medical literature, APS-2 affects fewer than 5 in 100,000 people, with onset typically occurring in adolescence or early adulthood. The condition is more common in women and often runs in families, though Emma has no known relatives with the syndrome.
A Race Against Time
Emma’s symptoms first appeared in early 2026, initially dismissed as stress-related exhaustion. By March, her health had deteriorated rapidly—she experienced severe dehydration, dizziness, and episodes of hypoglycemia that left her unable to function. A battery of tests at Lucile Packard Children’s Hospital Stanford revealed dangerously low cortisol levels and elevated blood sugar, confirming the dual diagnosis.
“We had to act fast,” Dr. Chen explained. “Addison’s disease can be fatal if untreated, and diabetes requires immediate insulin therapy. The combination meant we were fighting on two fronts.”
Emma now relies on a strict regimen of hormone replacement therapy—including hydrocortisone to replace cortisol and fludrocortisone for aldosterone—as well as insulin injections to manage her blood sugar. Her medical team has also implemented continuous glucose monitoring to track fluctuations in real time.
Why This Case Matters
Autoimmune disorders like APS-2 highlight the delicate balance of the endocrine system and the body’s ability to regulate vital functions. For patients and families, the diagnosis can be overwhelming, as it requires lifelong management of multiple chronic conditions. Experts emphasize the importance of early recognition, particularly when symptoms seem to overlap with more common illnesses like diabetes or thyroid disease.
“This case underscores the need for clinicians to consider rare autoimmune syndromes when patients present with unexplained, multisystem symptoms,” said Dr. Mark Reynolds, a pediatric endocrinologist not involved in Emma’s care. “A delayed diagnosis can have serious consequences.”
For Emma, the road to stability has been difficult but not without hope. “It’s been a lot to process,” she admitted in a recent interview. “But I’m learning to listen to my body and advocate for myself. If my story helps even one person obtain diagnosed sooner, it’s worth it.”
The Broader Picture
While APS-2 remains rare, autoimmune diseases collectively affect an estimated 24 million Americans, according to the American Autoimmune Related Diseases Association. Conditions like type 1 diabetes, rheumatoid arthritis, and lupus are more widely recognized, but lesser-known syndromes often fly under the radar, leading to delayed treatment and poorer outcomes.
Public health advocates stress the need for greater awareness among both medical professionals and the general public. “Autoimmune diseases don’t always present in textbook ways,” said Dr. Sarah Patel, a rheumatologist at UCSF Health. “Increased education and access to specialized care can craft a real difference in early intervention.”
For now, Emma is focused on adjusting to her new normal. With the support of her medical team and family, she’s returned to school and is gradually resuming activities she once took for granted. Her story serves as a reminder of the resilience required to navigate chronic illness—and the critical role of timely, accurate diagnosis in saving lives.
